Matricelf Ltd. is a biotechnology company, which engages in research and development of a platform for autologous matrix and cell implants in the field of regenerative medicine and tissue engineering. It offers spinal cord, myocardial infraction, and future pipelines solutions. The company was founded by Tal Dvir and Alon Sinai on April 18, 2019 and is headquartered in Ness Zion, Israel.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company